In this article, we will list the 5 Best Small Cap Stocks to Buy for Long Term. Please visit 12 Best Small Cap Stocks to Buy for Long Term if you would like to see the extended list and the methodology behind it.

5. United Parks & Resorts Inc. (NYSE:PRKS)

Number of Hedge Fund Holders: 24

United Parks & Resorts Inc. (NYSE:PRKS) is one of the best small cap stocks to buy for the long term. Mizuho lifted the price target on United Parks & Resorts Inc. (NYSE:PRKS) to $48 from $47 on May 12 and maintained an Outperform rating on the shares. United Parks & Resorts Inc. (NYSE:PRKS) also received a rating update from Stifel the same day. The firm downgraded the stock to Hold from Buy, bringing the price target on the stock down to $40 from $43. It told investors that although the firm ultimately believes in the quality of the company’s assets, with one shareholder, Hill Path, controlling about 70% of the shares, Stifel also believes that “the story isn’t about operational improvement/quality (or even demand/pricing) but more so about what that shareholder will do (or not do) to drive share performance”.

For additional reference, in its financial results for fiscal Q1 2026, United Parks & Resorts Inc. (NYSE:PRKS) reported that highlights attendance was 3.2 million guests, a decrease of approximately 171,000 guests from the prior year period, while total revenue was $278.3 million, reflecting a decrease of $8.7 million from the first quarter of 2025.

United Parks & Resorts Inc. (NYSE:PRKS) owns and operates theme parks. The company’s portfolio includes SeaWorld, Busch Gardens, Aquatica, Discovery Cove, Sesame Place, and Sea Rescue.

4. Flywire Corporation (NASDAQ:FLYW)

Number of Hedge Fund Holders: 28

Flywire Corporation (NASDAQ:FLYW) is one of the best small cap stocks to buy for the long term. Raymond James lifted the price target on Flywire Corporation (NASDAQ:FLYW) to $22 from $21 on May 27 and maintained an Outperform rating on the shares, telling investors in a research note that the firm is encouraged by the recent execution and the diversification of the business. It sees a credible path for upside to estimates as the year progresses.

JPMorgan upgraded Flywire Corporation (NASDAQ:FLYW) to Neutral from Underweight on May 21, lifting the price target on the company to $16 from $14. It told investors in a research note that the company’s execution on re-mixing the business makes it less vulnerable to negative earnings revision risk. The firm also believes that Flywire Corporation (NASDAQ:FLYW) has reset expectations, creating “far less” downside risk relative to a year ago with upside potential from its recent deals and pipeline. It added that the travel trends remain positive, with no notable impact from the Middle East conflict.

Flywire Corporation (NASDAQ:FLYW) is a payments enablement and software company that combines its global payments network, payments platform, and vertical-specific software to deliver important and complex payments for its clients and their customers.

3. NETSTREIT Corp. (NYSE:NTST)

Number of Hedge Fund Holders: 30

NETSTREIT Corp. (NYSE:NTST) is one of the best small cap stocks to buy for the long term. Jefferies assumed coverage of NETSTREIT Corp. (NYSE:NTST) with a Buy rating on June 1 and set a price target of $23. The firm assumed coverage of the retail net lease real estate investment trusts with a positive outlook and told investors in a research note that execution on investment pipelines will drive a re-rating to historical valuation multiples. It further stated that the net lease group trades at the third-highest discount to the 10 year-average in the REIT space, and this places net lease in the “same cohort as secular challenged sectors” such as office and lab despite “intact fundamentals”.

NETSTREIT Corp. (NYSE:NTST) also received a rating update from Truist on May 11. The firm lifted the price target on the stock to $22 from $21 and reiterated a Buy rating on the shares, stating that the firm slightly raised its FAD estimates and its price target on the company, supported by higher assumed acquisition volume.

NETSTREIT Corp. (NYSE:NTST) is an internally managed Real Estate Investment Trust specializing in acquiring single-tenant net lease retail properties nationwide. It is involved in acquiring, owning, and managing a diversified portfolio of single-tenant, net-lease retail commercial real estate.

2. Genius Sports Limited (NYSE:GENI)

Number of Hedge Fund Holders: 37

Genius Sports Limited (NYSE:GENI) is one of the best small cap stocks to buy for the long term. Deutsche Bank resumed coverage of Genius Sports Limited (NYSE:GENI) with a Buy rating on May 11 and set a price target of $10. The firm resumed coverage of the stock after it released its fiscal Q1 earnings report, stating that it believes the company is continuing to have “numerous ways to win” in the legacy sports betting business-to-business business to drive growth moving forward.

Genius Sports Limited (NYSE:GENI) also received a rating update from Oppenheimer on May 8. The firm cut the price target on the stock to $9 from $11 and maintained an Outperform rating on the shares, noting that the company delivered a solid fiscal Q1 revenue/EBITDA beat, which was driven by accelerating betting services revenue, and incorporating Legend Revenue/EBITDA of $185M/$90M into full year guidance, which are now $990M-$1.01B/$270-$280M. Oppenheimer also stated that it sees catalysts building into World Cup/NFL-Kickoff, with Street likely raising back-half Media revenue up on PMs, O&O inventory, and iGaming to better justify management’s strategy and generate some multiple expansion.

Genius Sports Limited (NYSE:GENI) provides scalable, technology-led products and services to the sports betting, sports, and sports media industries.

1. Immunocore Holdings plc (NASDAQ:IMCR)

Number of Hedge Fund Holders: 38

Immunocore Holdings plc (NASDAQ:IMCR) is one of the best small cap stocks to buy for the long term. Immunocore Holdings plc (NASDAQ:IMCR) announced on May 31 updated results from its Phase 1/2 trial evaluating brenetafusp in patients with heavily pretreated advanced melanoma, with the data presented in a poster at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Mohammed Dar, Chief Medical Officer of Immunocore Holdings plc (NASDAQ:IMCR), stated that the data with brenetafusp in heavily pretreated advanced melanoma exhibited “consistent responses and survival even in those with poor prognosis, including patients with primary PD-1 resistance”, adding that the data also reinforces the company’s “confidence in the potential of brenetafusp at the dose of 160 mcg in combination with nivolumab in first-line advanced melanoma, in the ongoing Phase 3 PRISM-MEL-301 trial”.

The company further reported that brenetafusp monotherapy led to a 6-month overall survival rate of 87% and disease control rate of 52% in heavily pretreated HLA-A*02:01-positive patients with melanoma, with management stating that the clinical benefit was consistent across difficult-to-treat subgroups, including patients with primary PD-1 resistance.

Immunocore Holdings plc (NASDAQ:IMCR) is a commercial-stage biotechnology company that pioneered the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. The company’s pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.